A phase II randomised, two-way crossover study to compare the steady state pharmacokinetics of testosterone following application of different testosterone metered-dose lotion doses in hypogonadal male subjects
Phase of Trial: Phase II
Latest Information Update: 18 Jun 2008
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics
- Sponsors Acrux DDS
- 18 Jun 2008 Status changed from in progress to completed, as reported by ClinicalTrials.gov.
- 16 Jul 2007 Interim results have been reported.
- 02 May 2007 Status changed from initiated to in progress.